PROGENICS PHARMACEUTICALS INC·4

Oct 4, 5:37 PM ET

MADDON PAUL J 4

4 · PROGENICS PHARMACEUTICALS INC · Filed Oct 4, 2010

Insider Transaction Report

Form 4
Period: 2010-10-04
MADDON PAUL J
DirectorChief Executive Officer/CSO
Transactions
  • Purchase

    Common Stock

    [F1]
    2010-10-04$4.99/sh+5,000$24,950844,057 total
Footnotes (1)
  • [F1]Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Signature
By: Robert A. McKinney For: Paul J. Maddon|2010-10-04

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT